Cornerstone Planning Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$930K Sell
3,637
-27
-0.7% -$6.29K 0.12% 77
2026
Q1
$826K Buy
3,664
+213
+6% +$49.6K 0.11% 76
2025
Q4
$786K Sell
3,451
-318
-8% -$62.9K 0.12% 67
2025
Q3
$713K Buy
3,769
+2,611
+225% +$447K 0.11% 72
2025
Q2
$198K Buy
1,158
+129
+13% +$19.8K 0.04% 87
2025
Q1
$160K Buy
1,029
+243
+31% +$38K 0.04% 101
2024
Q4
$120K Sell
786
-16
-2% -$2.48K 0.03% 101
2024
Q3
$128K Buy
802
+25
+3% +$3.98K 0.03% 97
2024
Q2
$125K Buy
777
+169
+28% +$25.1K 0.04% 115
2024
Q1
$90.7K Sell
608
-320
-34% -$50.9K 0.03% 122
2023
Q4
$145K Sell
928
-44
-5% -$6.75K 0.05% 96
2023
Q3
$151K Buy
972
+23
+2% +$3.79K 0.06% 90
2023
Q2
$157K Buy
+949
New +$153K 0.06% 101
2022
Q4
$230K Buy
+1,353
New +$234K 0.1% 89

Other funds holding JNJ

Cornerstone Planning Group's JNJ Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Johnson & Johnson (JNJ) stake by 0.74% in Q2 2026, selling an estimated $6.29K and leaving 3,637 shares worth $930K. The position accounts for 0.12% of the portfolio, ranked #77.

Cornerstone Planning Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cornerstone Planning Group held 3,637 shares of Johnson & Johnson worth $930K as of Q2 2026.
  • Cornerstone Planning Group sold 27 Johnson & Johnson shares in Q2 2026, an estimated $6.29K.
  • Johnson & Johnson made up 0.12% of Cornerstone Planning Group's portfolio in Q2 2026, its #77 holding.
  • Cornerstone Planning Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.